Save this page
Save this page

My Saved Pages

  • Saved page.

My Saved Courses

  • Saved page.
Reset

Recently visited

  • Saved page.

Dr Annette Sorensen

Teaching Associate

Strathclyde Institute of Pharmacy and Biomedical Sciences

Publications

Laser-plasma generated very high energy electrons (VHEEs) in radiotherapy
Kokurewicz K., Welsh G. H., Brunetti E., Wiggins S. M., Boyd M., Sorensen A., Chalmers A., Schettino G., Subiel A., DesRosiers C., Jaroszynski D. A.
Proceedings of SPIE 7982, Smart Sensor Phenomena, Technology, Networks, and Systems 2011 Vol 10239, (2017)
http://dx.doi.org/10.1117/12.2271183
Emulsion technologies for multicellular tumour spheroid radiation assays
McMillan Kay S., McCluskey Anthony G., Sorensen Annette, Boyd Marie, Zagnoni Michele
Analyst Vol 141, pp. 100-110, (2015)
http://dx.doi.org/10.1039/c5an01382h
Dosimetry of very high energy electrons (VHEE) for radiotherapy applications : using radiochromic film measurements and Monte Carlo simulations
Subiel Anna, Moskvin V., Welsh Gregor H., Cipiccia Silvia, Reboredo Gil David, Evans P., Partridge M., Desrosiers C., Anania Maria Pia, Cianchi A., Mostacci A., Chiadroni E., Di Giovenale D., Villa F., Pompili R., Ferrario M., Bellaveglia M., Di Pirro G., Gatti G., Vaccarezza C., Seitz Bjorn, Issac Riju, Brunetti Enrico, Wiggins Mark, Ersfeld Bernhard, Islam Mohammad, Mendonca M.S., Sorensen Annette, Boyd Marie, Jaroszynski Dino
Physics in Medicine and Biology Vol 59, pp. 5811–5829, (2014)
http://dx.doi.org/10.1088/0031-9155/59/19/5811
The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells
Rae Colin, Tesson Mathias, Babich John W, Boyd Marie, Sorensen Annette, Mairs Robert J
The Journal of Nuclear Medicine Vol 54, pp. 953-960 , (2013)
http://dx.doi.org/10.2967/jnumed.112.113324
Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21WAF1/CIP1 promoter
McCluskey Anthony G, Mairs Robert J, Sorensen Annette, Robson Tracy, McCarthy Helen O, Pimlott Sally L, Babich John W, Champion Sue, Boyd Marie
Radiation Research Vol 179, pp. 282-292, (2013)
http://dx.doi.org/10.1667/RR3030.1
The role of copper in disulfiram-induced toxicity and radiosensitisation of cancer cells.
Rae Colin, Tesson M., Babich John W, Boyd Marie, Sorensen Annette, Mairs Robert J.
The Journal of Nuclear Medicine, (2013)
http://dx.doi.org/10.2967/jnucmed.112.113324

more publications

Projects

Radiosensitisation of Glioblastoma multiforme (GBM)
Sorensen, Annette (Principal Investigator) Boyd, Marie (Co-investigator) Faulds, Karen (Co-investigator) Graham, Duncan (Co-investigator)
Period 01-Feb-2015 - 31-Mar-2017
BTG- Ultra Compact Particle and Radiation Source for the Treatment of Cancer
Boyd, Marie (Principal Investigator) Jaroszynski, Dino (Principal Investigator) Sorensen, Annette (Principal Investigator)
Researchers working within the Advanced Science and Technology theme, led by Professor Dino Jaroszynski, are developing ground-breaking laser-driven particle acceleration sources, which are far more compact than, but at least as powerful as, current systems. They are using intense, accelerated, ultra-short laser pulses to drive plasma-wakefield technology, which can fit in the palm of the hand, whereas current conventional devices can be as long as 100m. As well as creating more accessible equipment for cancer therapy, the technology created at Strathclyde has potential applications in the imaging of stored nuclear waste and the production of medical isotopes. A multidisciplinary team were awarded EPSRC funding from the Bridging the Gap initiative to develop an ultra‐compact particle and radiation source for the treatment of cancer. This research combined the disciplines of physical and life sciences to create a potentially ground breaking technology. The support of seed funding from BTG has allowed the research team to progress the research and win further funding of £250,000 from the Chief Scientists Office to develop this research into a technology of interest to the health sector. In order to identify the ways in which this technology could be adopted by external organisations, such as the NHS, the University engaged Dr Peter Keenan, who has been working as a consultant for the NHS for a number of years. This has resulted in a detailed project plan for advancement of the technology to reach the clinical trials stage, with the aim of the NHS adopting this groundbreaking technology. Additionally, the Principal Investigator's named on this grant, along with other collaborators, have been successful in their application to EPSRC and have won over £3million. As part of this grant, entitled "Collective Radiation-Beam-Plasma Interactions at High Intensities", the use of this technology in the treatment of cancer will be further investigated and developed.
Period 01-Aug-2011
Novel combination therpaies for the treatment of medulloblastoma
Sorensen, Annette (Principal Investigator) Boyd, Marie (Co-investigator)
Period 01-Dec-2010 - 31-May-2012

more projects

Address

Strathclyde Institute of Pharmacy and Biomedical Sciences

Location Map

View University of Strathclyde in a larger map